D
Verastem, Inc. VSTM
$4.64 $0.122.66% NASDAQ
Recommendation
Prev Close
$4.64
Volume
824,199
Avg Vol (90D)
1,229,249
Market Cap
$238.90M
Dividend & Yield
--
52-Week Range
$2.10 - $13.52
P/E (TTM)
--
EPS (TTM)
-$3.50
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Verastem (VSTM, $4.64) Aroon Indicator entered a Downtrend on April 11, 2025.
4/12/2025 - Tickeron - Stocks
Mizuho Lowers Verastem (NASDAQ:VSTM) Price Target to $8.00
4/11/2025 - MarketBeat
Verastem (VSTM, $4.52) Aroon Indicator entered a Downtrend on April 10, 2025.
4/11/2025 - Tickeron - Technical Analysis
Verastem: RAMP-203 Study Could Be Next Big Win For Avutometinib Combination
4/10/2025 - Seeking Alpha - Long Ideas
Verastem: RAMP-203 Study Could Be Next Big Win For Avutometinib Combination
4/10/2025 - SeekingAlpha
Mizuho Lowers Verastem (NASDAQ:VSTM) Price Target to $8.00
4/10/2025 - Ticker Report
Verastem (VSTM): Jefferies Initiates Coverage with Buy Rating Amid FDA Review
4/10/2025 - GuruFocus
Verastem initiated Buy at Jefferies on a potential FDA nod for ovarian cancer therapy
4/10/2025 - Seeking Alpha - Healthcare
Verastem (VSTM) Receives Buy Rating from Jefferies with Promising Outlook VSTM Stock News
4/10/2025 - GuruFocus
Verastem initiated with bullish view at Jefferies, here's why
4/10/2025 - The Fly
Verastem (VSTM, $5.28) Aroon Indicator entered a Downtrend on April 09, 2025.
4/10/2025 - Tickeron - Stocks
Verastem (VSTM, $5.28) RSI Indicator left the oversold zone on April 09, 2025
4/10/2025 - Tickeron - Stocks
Verastem price target lowered by $1 at Mizuho, here's why
4/9/2025 - The Fly
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4/7/2025 - GuruFocus
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4/7/2025 - Business Wire
Verastem (VSTM, $5.16) RSI Indicator left the oversold zone on April 04, 2025
4/5/2025 - Tickeron - Stocks
Verastem Oncology Reports Progress in Cancer Treatments
4/3/2025 - TipRanks Financial Blog
Verastem, Inc. (NASDAQ:VSTM) Short Interest Update
4/2/2025 - MarketBeat
AIGH Capital Management LLC Purchases Shares of 2,665,043 Verastem, Inc. (NASDAQ:VSTM)
3/31/2025 - MarketBeat
Wall Street Analysts Believe Verastem (VSTM) Could Rally 100.94%: Here's is How to Trade
3/27/2025 - Zacks Investment Research
Verastem (NASDAQ:VSTM) Upgraded to "Hold" at StockNews.com
3/26/2025 - MarketBeat
Verastem Oncology Announces Multiple Presentations Focused on RAS/MAPK Pathway Inhibition at ...
3/25/2025 - GuruFocus
Verastem Oncology Announces Multiple Presentations Focused on RAS/MAPK Pathway Inhibition at AACR Annual Meeting 2025
3/25/2025 - Business Wire
Verastem (NASDAQ:VSTM) Price Target Raised to $14.00
3/25/2025 - MarketBeat
Verastem (NASDAQ:VSTM) Given New $10.00 Price Target at HC Wainwright
3/25/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$10.00M
EBITDA (TTM)
-$114.93M
EBIT (TTM)
-$114.96M
Net Income (TTM)
-$130.64M
Balance Sheet
Total Assets (Q)
$101.54M
Total Debt (Q)
$42.25M
Total Liabilities (Q)
$130.43M
Book Value Per Share (Q)
-$0.6452
Cash Flow
Cash from Operations (TTM)
-$104.77M
Cash from Investing (TTM)
$59.97M
Cash from Financing (TTM)
$54.78M
Net Change in Cash (TTM)
$9.98M
Filings
Filing Date
Thursday, March 20, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Created with Highstock 5.0.142. Dec9. Dec16. Dec23. Dec30. Dec6. Jan13. Jan20. Jan27. Jan3. Feb10. Feb17. Feb24. Feb3. Mar10. Mar17. Mar24. Mar31. Mar7. Apr$2.00$4.00$6.00$8.00Price as of Apr 11, 2025
Beta
2.16
7-Day Total Return
-18.60%
30-Day Total Return
-16.25%
60-Day Total Return
-12.12%
90-Day Total Return
-15.94%
Year to Date Total Return
-28.51%
1-Year Total Return
-58.94%
2-Year Total Return
1.75%
3-Year Total Return
-73.70%
5-Year Total Return
-87.36%
52-week Low
Aug 05, 2024 - $2.10
52-week High
May 15, 2024 - $13.52
Valuation
Market Cap
$238.90M - Micro Cap
Enterprise Value
$192.33M
Price/Sales (TTM)
22.60
Price/Book (Q)
-7.19
Dividends and Shares
Shares Outstanding
48.71M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.verastem.com
Phone Number
781 292 4200
Address
117 Kendrick Street
Needham, MA 02494
Country
United States
Year Founded
2010
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Verastem, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States. Its product candidates are... more
NASDAQ 04/11/2025 4:00PM Eastern Quotes delayed